These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11267585)

  • 1. Safety of continuous human liver support.
    Millis JM; Cronin DC; Johnson R; Conjeevaram H; Brady L; Trevino S; Conlin C; Brotherton J; Traglia D; Dane G; Maguire P
    Transplant Proc; 2001; 33(1-2):1954. PubMed ID: 11267585
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracorporeal liver perfusion.
    McChesney LP; Fagan EA; Rowell DL; Del Rio JV; Fabrega F; Millis M; Williams JW
    Lancet; 1999 Jan; 353(9147):120-1. PubMed ID: 10023904
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioartificial liver support: report of the longest continuous treatment with human hepatocytes.
    Millis JM; Cronin DC; Johnson R; Conjeevaram H; Faust TW; Trevino S; Conlin C; Brotherton J; Traglia D; Maguire P; Dane G
    Transplant Proc; 2001; 33(1-2):1935. PubMed ID: 11267578
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver support in acute liver failure.
    Hughes RD
    Wien Klin Wochenschr; 2003 Sep; 115(15-16):547-8. PubMed ID: 14531165
    [No Abstract]   [Full Text] [Related]  

  • 5. Technical problems with a model of ex vivo liver perfusion in the pig.
    Boggi U; Bellini R; Vistoli F; Capellini S; Kusmic C; Campani D; Barbieri U; Sartucci F; Burchielli S; Trivella MG; Filipponi F; Mosca F
    Transplant Proc; 2000 Dec; 32(8):2726-9. PubMed ID: 11134776
    [No Abstract]   [Full Text] [Related]  

  • 6. Artificial liver support devices as treatment option for liver failure.
    Nevens F; Laleman W
    Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):17-26. PubMed ID: 22482522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survivors with artificial liver support in fulminant hepatic failure.
    Nitta M; Hirasawa H; Oda S; Shiga H; Nakanishi K; Matsuda K; Nakamura M; Yokohari K; Hirano T; Hirayama Y; Moriguchi T; Watanabe E
    Ther Apher; 2002 Jun; 6(3):208-12. PubMed ID: 12109945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporary neurological improvement in a patient with acute or chronic liver failure treated with a bioartificial liver device.
    Donini A; Baccarani U; Risaliti A; Degrassi A; Bresadola F
    Am J Gastroenterol; 2000 Apr; 95(4):1102-4. PubMed ID: 10763984
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of MARS in the treatment of acute liver failure: preliminar monocentric experience.
    Novelli G; Rossi M; Pretagostini R; Poli L; Peritore D; Berloco P; Di Nicuolo A; Iappelli M; Cortesini R
    Transplant Proc; 2001; 33(1-2):1942-4. PubMed ID: 11267580
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental study of plasma recycling system by off-line bioartificial liver in rats.
    Ikeda T; Aoki T; Miyashita T; Kasuya K; Tsuchida A; Koyanagi Y; Matsumura T; Suzuki S; Enosawa S
    Transplant Proc; 2002 Nov; 34(7):2706-10. PubMed ID: 12431582
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of artificial liver support system on patients with acute or chronic liver failure.
    Du WB; Li LJ; Huang JR; Yang Q; Liu XL; Li J; Chen YM; Cao HC; Xu W; Fu SZ; Chen YG
    Transplant Proc; 2005 Dec; 37(10):4359-64. PubMed ID: 16387120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in critical care hepatology.
    Marrero J; Martinez FJ; Hyzy R
    Am J Respir Crit Care Med; 2003 Dec; 168(12):1421-6. PubMed ID: 14668256
    [No Abstract]   [Full Text] [Related]  

  • 13. [Side-effects and management of continuous MARS artifical liver for patients].
    Wang X; Zhou XM; Miao JY; Yang Y; Zhao L; Ding J; Wu KC; Fan DM
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):15. PubMed ID: 14761274
    [No Abstract]   [Full Text] [Related]  

  • 14. Further experience of late onset hepatic failure.
    Ellis AJ; Portmann B; Gimson AE; Williams R
    Indian J Gastroenterol; 1993 Dec; 12 Suppl 3():15-8. PubMed ID: 8005629
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver transplantation and artificial liver support in fulminant hepatic failure.
    Zhu XF; Chen GH; He XS; Lu MQ; Wang GD; Cai CJ; Yang Y; Huang JF
    World J Gastroenterol; 2001 Aug; 7(4):566-8. PubMed ID: 11819831
    [No Abstract]   [Full Text] [Related]  

  • 16. Extracorporeal artificial liver support in hepatic failure: pathfinder, bridge to recovery or dead end street?
    Fuhrmann V; Derfler K; Trauner M
    Liver Int; 2011 Sep; 31 Suppl 3():iv. PubMed ID: 21824273
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of Human Hepatoma Cell-Line Constructing Bioartificial Liver Supporting System Treating Patients with Liver Failure.
    You S; Zhu B; Liu H; Rong Y; Liu W; Zang H; Zhang A; Wan Z; Xin S
    Hepatogastroenterology; 2014 Jun; 61(132):933-6. PubMed ID: 26158144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial liver support system for fulminant hepatic failure as bridge-use to living donor liver transplantation.
    Ichida T
    Intern Med; 2003 Oct; 42(10):920-1. PubMed ID: 14606698
    [No Abstract]   [Full Text] [Related]  

  • 19. A liver transplant center experience with liver dialysis in the management of patients with fulminant hepatic failure: a preliminary report.
    Aladağ M; Gürakar A; Jalil S; Wright H; Alamian S; Rashwan S; Sebastian A; Nour B
    Transplant Proc; 2004; 36(1):203-5. PubMed ID: 15013346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal liver support: cell-based therapy for the failing liver.
    Sussman NL; Kelly JH
    Am J Kidney Dis; 1997 Nov; 30(5 Suppl 4):S66-71. PubMed ID: 9372981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.